Series date: 
01/03/2024 - 8:00am CST to 12/31/2024 - 9:00am CST

Location

OPC 22/Teams Virtual


Frequency

Weekly- Wednesdays


Series Director

Sudha Kodali, MD


Overview

The incidence of hepatocellular Carcinoma is rising worldwide and evaluations and treatments are rapidly changing. This continuing medical education activity is designed to provide a comprehensive assessment and discussion of multidisciplinary approaches to treating primary and secondary liver tumors, addressing the timing and types of treatments that best fit individual patient characteristics who have primary and secondary liver tumors. 


Target Audience and Needs

The target audience for this activity is: physicians, nurses, and health professionals in hepatology, diagnostic radiology, oncology and surgery. 


Objectives

At the conclusion of this activity, the participant should be able to:

  • Define liver tumors using illustrated guide to systematic radiologic diagnosis and staging according to AASLD.
  • Identify and stage new onset and existing liver tumors using a radiologic systematic approach
  • Interpret the background of treatment and management of Hepatocellular Carcinoma and be able to identify primary and secondary liver tumors in different case studies. 
Series location: 
OPC 22
United States

Sessions

Session Date
Hepatobiliary Tumor Conference 01/03/2024 - 8:00am to 9:00am CST
Hepatobiliary Tumor Conference 01/10/2024 - 8:00am to 9:00am CST
Hepatobiliary Tumor Conference 01/17/2024 - 8:00am to 9:00am CST
Hepatobiliary Tumor Conference 01/24/2024 - 8:00am to 9:00am CST
Hepatobiliary Tumor Conference 01/31/2024 - 8:00am to 9:00am CST
Hepatobiliary Tumor Conference 02/07/2024 - 8:00am to 9:00am CST
Hepatobiliary Tumor Conference 02/14/2024 - 8:00am to 9:00am CST
Hepatobiliary Tumor Conference 02/21/2024 - 8:00am to 9:00am CST
Hepatobiliary Tumor Conference 02/28/2024 - 8:00am to 9:00am CST
Hepatobiliary Tumor Conference 03/06/2024 - 8:00am to 9:00am CST

Pages